Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1971 1
1975 1
1978 1
1980 1
1981 1
1982 1
1983 2
1984 3
1985 5
1986 6
1987 5
1988 4
1989 6
1990 12
1991 11
1992 18
1993 21
1994 27
1995 33
1996 29
1997 48
1998 43
1999 35
2000 31
2001 26
2002 22
2003 27
2004 23
2005 34
2006 38
2007 48
2008 39
2009 36
2010 44
2011 60
2012 51
2013 45
2014 30
2015 48
2016 48
2017 45
2018 40
2019 41
2020 34
2021 31
2022 21
2023 22
2024 24
2025 25
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,155 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Tetanus Toxoid Vaccination Coverage and Associated Factors among Childbearing Women in Ethiopia: A Systematic Review and Meta-Analysis.
Nigussie J, Girma B, Molla A, Mareg M. Nigussie J, et al. Biomed Res Int. 2021 Nov 8;2021:5529315. doi: 10.1155/2021/5529315. eCollection 2021. Biomed Res Int. 2021. PMID: 34790820 Free PMC article.
Globally, maternal and neonatal tetanus is a public health problem due to low maternal tetanus toxoid immunization. Ethiopia has the highest neonatal mortality and morbidity related to tetanus due to low tetanus toxoid immunization and th …
Globally, maternal and neonatal tetanus is a public health problem due to low maternal tetanus toxoid immunization. Eth …
Tetanus toxoid immunization to reduce mortality from neonatal tetanus.
Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Blencowe H, et al. Int J Epidemiol. 2010 Apr;39 Suppl 1(Suppl 1):i102-9. doi: 10.1093/ije/dyq027. Int J Epidemiol. 2010. PMID: 20348112 Free PMC article.
BACKGROUND: Neonatal tetanus remains an important and preventable cause of neonatal mortality globally. Large reductions in neonatal tetanus deaths have been reported following major increases in the coverage of tetanus toxoid immunization, yet the lev …
BACKGROUND: Neonatal tetanus remains an important and preventable cause of neonatal mortality globally. Large reductions in neonatal …
Tetanus toxoid vaccination coverage and associated factors among pregnant women in East Africa: systematic review and meta-analysis.
Taye BA, Weldearegay BY, Yirsaw BG, Belete AK. Taye BA, et al. BMC Public Health. 2025 Oct 3;25(1):3319. doi: 10.1186/s12889-025-24687-9. BMC Public Health. 2025. PMID: 41044529 Free PMC article.
Despite several studies examining tetanus toxoid vaccine coverage in East Africa, the total pooled vaccination coverage rate remains unknown, and the results of these studies are related to these variables. The purpose of this meta-analysis is to estimate the pooled …
Despite several studies examining tetanus toxoid vaccine coverage in East Africa, the total pooled vaccination coverage rate r …
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ. Munoz FM, et al. JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633. JAMA. 2014. PMID: 24794369 Free PMC article. Clinical Trial.
IMPORTANCE: Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine could prevent infant pertussis. OBJECTIVE: To evaluate the safety and immunogenicity of Tdap immunization during pregnancy and its effect …
IMPORTANCE: Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccin …
Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
Zambrano B, Peterson J, Deseda C, Julien K, Spiegel CA, Seyler C, Simon M, Hoki R, Anderson M, Brabec B, Áñez G, Shi J, Pan J, Hagenbach A, Von Barbier D, Varghese K, Jordanov E, Dhingra MS. Zambrano B, et al. Pediatr Res. 2023 Sep;94(3):1035-1043. doi: 10.1038/s41390-023-02478-5. Epub 2023 Mar 10. Pediatr Res. 2023. PMID: 36899125 Free PMC article. Clinical Trial.
BACKGROUND: The immunogenicity and safety of a booster dose of tetanus toxoid-conjugate quadrivalent meningococcal vaccine (MenACYW-TT), alone or co-administered with MenB vaccine, were assessed in healthy 13-25-year olds who received MenACYW-TT or a CRM-conjugate v …
BACKGROUND: The immunogenicity and safety of a booster dose of tetanus toxoid-conjugate quadrivalent meningococcal vaccine (Me …
Efficacy and Safety of Tetanus-Toxoid Conjugate Typhoid Vaccine (Vi-TT) in Children and Adolescents: A Systematic Review and Meta-Analysis.
Gyawali R, Poudyal N, Docherty A. Gyawali R, et al. Asia Pac J Public Health. 2025 Nov;37(8):628-637. doi: 10.1177/10105395251362546. Epub 2025 Aug 11. Asia Pac J Public Health. 2025. PMID: 40788116
This review assessed the efficacy, safety, and immunogenicity of the tetanus toxoid conjugate typhoid vaccine (Vi-TT) in children and adolescents. Randomized controlled trials involving Vi-TT in individuals under 18 were included. ...
This review assessed the efficacy, safety, and immunogenicity of the tetanus toxoid conjugate typhoid vaccine (Vi-TT) in child …
Perinatal mortality and its association with antenatal care visit, maternal tetanus toxoid immunization and partograph utilization in Ethiopia: a meta-analysis.
Desta M, Akalu TY, Alamneh YM, Talie A, Alemu AA, Tessema Z, Yibeltal D, Alamneh AA, Ketema DB, Shiferaw WS, Getaneh T. Desta M, et al. Sci Rep. 2021 Oct 4;11(1):19641. doi: 10.1038/s41598-021-98996-5. Sci Rep. 2021. PMID: 34608180 Free PMC article.
Women who had antenatal care visit [OR = 0.20 (95% CI 0.12, 0.34)], maternal tetanus toxoid immunization [OR = 0.43 (95% CI 0.24, 0.77)] and partograph monitoring [POR = 0.22 (95% CI 0.06, 0.76)] reduced the risk of perinatal mortality. ...Therefore, antenatal care …
Women who had antenatal care visit [OR = 0.20 (95% CI 0.12, 0.34)], maternal tetanus toxoid immunization [OR = 0.43 (95% CI 0. …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Aydin I, May M, Pisano F, Mpofu-Maetzig N, Grode L, Parekh S, Pujari P, Shewale S, Desai S, Sharma H, Rao H, Gautam M, Gairola S, Shaligram U. Aydin I, et al. Vaccine. 2023 Nov 2;41(46):6810-6819. doi: 10.1016/j.vaccine.2023.09.060. Epub 2023 Oct 10. Vaccine. 2023. PMID: 37827966 Clinical Trial.
BACKGROUND: This study assessed the safety and immunogenicity of a new booster vaccine against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd (SIIPL Tdap). ...The study assessed safety and reactogenicity of SIIPL Tdap compared to the c …
BACKGROUND: This study assessed the safety and immunogenicity of a new booster vaccine against tetanus, diphtheria, and pertussis man …
Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology.
Pöllabauer EM, Petermann R, Ehrlich HJ. Pöllabauer EM, et al. Hum Vaccin. 2005 Jul-Aug;1(4):131-9. doi: 10.4161/hv.1.4.2018. Epub 2005 Jul 13. Hum Vaccin. 2005. PMID: 17012872 Review.
A conjugate vaccine comprised of de-O-acetylated group C meningococcal polysaccharide coupled to tetanus toxoid (GCMP-TT) has been licensed in 32 countries and incorporated in a comprehensive UK vaccination program. ...
A conjugate vaccine comprised of de-O-acetylated group C meningococcal polysaccharide coupled to tetanus toxoid (GCMP-TT) has …
Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.
Choi UY, Kim KH, Lee J, Eun BW, Kim HM, Lee KY, Kim DH, Ma SH, Lee J, Kim JH. Choi UY, et al. J Korean Med Sci. 2021 Dec 20;36(49):e313. doi: 10.3346/jkms.2021.36.e313. J Korean Med Sci. 2021. PMID: 34931494 Free PMC article. Clinical Trial.
BACKGROUND: Although the combination tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) is recommended at adolescence in developed countries, the tetanus and diphtheria toxoid vaccine (Td), which is less costly, is …
BACKGROUND: Although the combination tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) …
1,155 results